Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 2142-2148, September 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joncas, J.
Right arrow Articles by Granger-Julien, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joncas, J.
Right arrow Articles by Granger-Julien, M.

Effect of Hydrocortisone on Cell Viability, Epstein-Barr Virus Genome Expression, and Interferon Synthesis in Human Lymphoblastoid Cell Lines1

Jean Joncas, Jocelyne Boucher, Armand Boudreault and Maryse Granger-Julien

Institute of Microbiology and Hygiene of Montreal [J. J., J. B., A. B., M. G.-J.], the Department of Microbiology [J. J.], and the Department of Pediatrics [J. J.], University of Montreal, Montreal, Quebec, Canada

The effect of hydrocortisone on six human lymphoblastoid cell lines was measured in relation to cell growth, number of Epstein-Barr (EB) virus antigen-positive cells, number of EB virus particles, and interferon synthesis. In two of the six cell lines (HRIK, MCI), hydrocortisone, in proportion to the dose, adversely affected cell viability concomitantly enhancing the expression of the EB virus genome. Recovery of normal viability in these two cell lines or lack of effect in the other three cell lines (EB3, Roswell Park Memorial Institute 1788, and AGI) appeared to be related to interferon synthesis. The observed effects occurred only in cell lines (HRIK, MCI) showing no detectable interferon prior to hydrocortisone, and recovery in these cell lines coincided with the appearance of detectable interferon. Conversely, in the three cell lines where interferon was either already present (AGI) or appeared within 3 days (EB3, Roswell Park Memorial Institute 1788), no adverse effect on cell viability and no definite activation of the EB virus genome could be demonstrated. In Raji, a few antigen-positive cells (4 to 23 per 105 cells) appeared but no viral particles. Cell viability was virtually unaltered and interferon was not detected. In Raji following bromodeoxyuridine (20 mg/ml) up to 1200 antigen-positive cells per 105 cells appeared with an associated interferon response. Priming of the HRIK cells with performed human interferon, 500 to 1000 units/ml of cell suspension for 72 hr or more prevented the adverse effect of hydrocortisone (20 to 100 µg/ml) on cell viability. These findings may help to reestablish a relationship between interferon synthesis and viral replication in EB virus-carrying lymphoblastoid cell lines.

1 Medical Research Council Grant MA 3197 and Federal Provincial Public Health Research Grant 604-7-783.

Received 4/ 2/73. Accepted 5/10/73.




This article has been cited by other articles:


Home page
ScienceHome page
S. Rich
Human lupus inclusions and interferon
Science, August 14, 1981; 213(4509): 772 - 775.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.